Drug Reduces Brain Damage Caused by Anesthesia
NYU Langone study finds an experimental drug prevented learning deficits caused by general anesthesia in a research model.
Drug Relieves Brain Sluggishness in Adults with ADHD
NYU Langone study shows that a drug known to stimulate brain activity reduces symptoms of sluggish cognitive tempo in adults with ADHD.
Drug Shows Promise for Metastatic Non-Small Cell Lung Cancer
Dr. Joshua K. Sabari, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, presented the results of a promising lung cancer drug.
Drug Shows Promise for Subset of Non-Small Cell Lung Cancer
NYU Langone medical oncologist Dr. Vamsidhar Velcheti discusses a promising treatment for people with a subset of non-small cell lung cancer.
Drug Target Identified for Common Childhood Blood Cancer
NYU Langone researchers describe advanced genetic scanning techniques to identify a possible new drug target for acute lymphoblastic leukemia.
Drug Targets Folate Receptor in Ovarian Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center is testing a highly selective drug for people with platinum-sensitive ovarian cancer.
dual-use-research-of-concern-flowchart.pdf
E-Cigarette Smoke Causes Lung Cancer in Mice
NYU Langone researchers found that exposure to e-cigarette vaping smoke caused mice to develop lung cancer.
E-Cigarettes May Lead to Increased Tobacco Use
NYU Langone researchers find use of e-cigarettes and other alternative tobacco products may lead to increased tobacco use later in life.
E-Cigarettes Possibly Linked to Erectile Dysfunction
New research from NYU Langone finds link between men with no history of heart disease who use e-cigarettes daily and erectile dysfunction.